Details for New Drug Application (NDA): 012015
✉ Email this page to a colleague
NDA 012015 describes COGENTIN, which is a drug marketed by Epic Pharma Llc and Merck and is included in two NDAs. Additional details are available on the COGENTIN profile page.
The generic ingredient in COGENTIN is benztropine mesylate. There are seven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the benztropine mesylate profile page.
The generic ingredient in COGENTIN is benztropine mesylate. There are seven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the benztropine mesylate profile page.
Summary for 012015
| Tradename: | COGENTIN |
| Applicant: | Epic Pharma Llc |
| Ingredient: | benztropine mesylate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 012015
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
